1. Home
  2. HCI vs STOK Comparison

HCI vs STOK Comparison

Compare HCI & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCI Group Inc.

HCI

HCI Group Inc.

HOLD

Current Price

$176.64

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.56

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCI
STOK
Founded
2006
2014
Country
United States
United States
Employees
594
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HCI
STOK
Price
$176.64
$29.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$230.00
$39.20
AVG Volume (30 Days)
140.4K
773.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
$11.44
N/A
Revenue Next Year
$7.67
$77.49
P/E Ratio
$9.97
N/A
Revenue Growth
N/A
404.50
52 Week Low
$136.37
$12.25
52 Week High
$210.50
$40.22

Technical Indicators

Market Signals
Indicator
HCI
STOK
Relative Strength Index (RSI) 53.50 47.19
Support Level $176.10 $28.22
Resistance Level $182.62 $33.51
Average True Range (ATR) 4.75 1.64
MACD -1.12 -0.11
Stochastic Oscillator 37.62 41.12

Price Performance

Historical Comparison
HCI
STOK

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: